B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 808 ILS -2.53% Market Closed
Market Cap: 594m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Brainsway Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Total Liabilities & Equity
$63m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
13%
Nano-X Imaging Ltd
NASDAQ:NNOX
Total Liabilities & Equity
$218.6m
CAGR 3-Years
-3%
CAGR 5-Years
158%
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Total Liabilities & Equity
$824m
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Total Liabilities & Equity
$626.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Total Liabilities & Equity
$43.5m
CAGR 3-Years
108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Total Liabilities & Equity
$40.3m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Glance View

Market Cap
594m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 161.92 ILS
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
63m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Total Liabilities & Equity amounts to 63m USD.

What is Brainsway Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
13%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Brainsway Ltd have been 23% over the past three years , 22% over the past five years , and 13% over the past ten years .

Back to Top